AnaptysBio, Inc. held its 2024 Annual Meeting of Stockholders and adopted proposals including the election of directors, ratification of the appointment of KPMG LLP as the independent registered public accounting firm, approval of executive compensation, and approval of the amendment and restatement of the 2017 Equity Incentive Plan.